Table 2. Clinical characteristics.
Characteristic |
First data set (N1=121) |
Second data set (N2=166) |
Overall (N=287) | ||||
---|---|---|---|---|---|---|---|
Bone marrow uninvolved (N=69) | Bone marrow involved (N=52) | P-value | Bone marrow uninvolved (N=74) | Bone marrow involved (N=92) | P-value | P-value | |
Histological subtype—% | 0.69 | 0.55 | 0.92 | ||||
Grade 1 | 29 | 29 | 53 | 48 | |||
Grade 2 | 55 | 50 | 43 | 48 | |||
Grade 3A | 16 | 21 | 4 | 4 | |||
Male sex—% | 49 | 56 | 0.48 | 54 | 49 | 0.51 | 0.95 |
Age >60 years—% | 52 | 37 | 0.087 | 35 | 29 | 0.43 | 0.046 |
LDH elevated—% | 33 | 31 | 0.77 | 20 | 36 | 0.028 | 0.17 |
Hemoglobin <12 g/dl—% | 3 | 8 | 0.23 | 14 | 24 | 0.091 | 0.016 |
>4 nodal areas involved—% | 13 | 56 | <0.0001 | 35 | 71 | <0.0001 | <0.0001 |
B symptoms—% | 14 | 33 | 0.017 | 23 | 24 | 0.89 | 0.099 |
Abbreviation: LDH, lactate dehydrogenase.